Multiplexed coronavirus serological testing for examining vaccine efficacy
SARS-CoV-2 is the major health threat across the globe at present. Vaccine development for this novel coronavirus has become the top priority for various research, health, and governmental entities. Sensitive and accurate testing is necessary to determine vaccine efficacy, serological response extent, and antibody formation.
Download this brochure from InDevR to learn how the VaxArray® Coronavirus SeroAssay kit can
Analyze antibody responses against multiple coronaviruses
Deliver quantitative serological response results
Provide greater sensitivity than standard ELISA testing
